SS
ABOS icon

SBI Securities’s Acumen Pharmaceuticals ABOS Stock Holding History

SBI Securities’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$715 Sell
303
-20
-6% -$51 ﹤0.01% 2773
2025
Q4 		$682 Sell
323
-195
-38% -$387 ﹤0.01% 2763
2025
Q3 		$886 Buy
518
+5
+1% +$7 ﹤0.01% 2746
2025
Q2 		$595 Hold
513
– – ﹤0.01% 2899
2025
Q1 		$564 Buy
513
+73
+17% +$104 ﹤0.01% 2820
2024
Q4 		$757 Buy
+440
New +$1.06K ﹤0.01% 2735

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

SBI Securities's ABOS Position: Q1 2026 in Review

SBI Securities reduced its Acumen Pharmaceuticals (ABOS) stake by 6.2% in Q1 2026, selling an estimated $51 and leaving 303 shares worth $715. The position accounts for ﹤0.01% of the portfolio, ranked #2773.

SBI Securities first reported a position in ABOS in Q4 2024 and has held it in 6 quarters since. The position peaked at $886 in Q3 2025. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • SBI Securities held 303 shares of Acumen Pharmaceuticals worth $715 as of Q1 2026.
  • SBI Securities sold 20 Acumen Pharmaceuticals shares in Q1 2026, an estimated $51.
  • Acumen Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2773 holding.
  • SBI Securities first reported a position in Acumen Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Acumen Pharmaceuticals position peaked at $886 in Q3 2025.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.